Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 10 reviews

530%
440%
330%
20%
10%
Ask AI

What reviewers say about MIFCOR

Based on 10 reviews on Trustburn · updated 47 days ago

Customers frequently describe MIFCOR's products as high quality and reliable, and they often praise the staff as friendly, knowledgeable, and helpful, with several mentioning easy ordering and good customer service. Reviews are largely positive, though a few are more neutral, and there are no mentions of recurring problems across the available feedback.
What does MIFCOR do?

MIFCOR is developing a first-in-class biologic therapeutic called MIF-2 that is designed to protect tissue from cell death caused by reduced blood flow, known as ischemia, by targeting a novel biological pathway. The company has executed an exclusive option on an IP portfolio and is in the process of building a business plan.

What are the most common complaints about MIFCOR?

Based on the reviews available, there are no clear or common complaints about MIFCOR, as customers generally describe positive experiences with product quality, customer service, and reliability.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About MIFCOR

MIFCOR is addressing this great need by developing a first-in-class biologic therapeutic for protecting tissue from cell death following reduced blood flow (ischemia). Their therapeutic, MIF-2, takes advantage of breakthrough science: by targeting a novel biological pathway, it protects tissue from ischemia-induced death. They successfully executed an exclusive option on an IP portfolio and building a business plan.